| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
|
Arch Neurol
|
2003
|
3.80
|
|
2
|
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
|
CMAJ
|
2010
|
3.46
|
|
3
|
Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat.
|
Pain
|
2004
|
2.60
|
|
4
|
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.
|
Pain
|
2006
|
2.51
|
|
5
|
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.
|
Cancer
|
2003
|
2.48
|
|
6
|
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.
|
Pain
|
2004
|
2.34
|
|
7
|
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.
|
Pain
|
2009
|
2.01
|
|
8
|
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.
|
Neuroimmunomodulation
|
2004
|
1.87
|
|
9
|
The role of sodium channels in chronic inflammatory and neuropathic pain.
|
J Pain
|
2006
|
1.59
|
|
10
|
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.
|
Exp Neurol
|
2006
|
1.59
|
|
11
|
Abnormal contralateral pain responses from an intradermal injection of phenylephrine in a subset of patients with complex regional pain syndrome (CRPS).
|
Pain
|
2004
|
1.55
|
|
12
|
Increasing placebo responses over time in U.S. clinical trials of neuropathic pain.
|
Pain
|
2015
|
1.55
|
|
13
|
C-fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long-term infusion of lidocaine yielding nanogram per milliliter plasma levels.
|
Pain
|
2008
|
1.49
|
|
14
|
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.
|
Exp Neurol
|
2007
|
1.47
|
|
15
|
Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.
|
Pain
|
2007
|
1.44
|
|
16
|
Dietary fat and protein interact in suppressing neuropathic pain-related disorders following a partial sciatic ligation injury in rats.
|
Pain
|
2004
|
1.43
|
|
17
|
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy.
|
Anesth Analg
|
2006
|
1.40
|
|
18
|
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
|
Neurosci Lett
|
2006
|
1.33
|
|
19
|
Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury.
|
J Comp Neurol
|
2006
|
1.25
|
|
20
|
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.
|
Exp Neurol
|
2011
|
1.24
|
|
21
|
Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice.
|
Mol Pain
|
2010
|
1.18
|
|
22
|
Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel.
|
Pain
|
2009
|
1.14
|
|
23
|
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.
|
BMC Neurol
|
2011
|
1.11
|
|
24
|
Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.
|
Pain
|
2012
|
1.11
|
|
25
|
Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain.
|
Pain
|
2008
|
1.07
|
|
26
|
Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia.
|
Sci Transl Med
|
2011
|
1.05
|
|
27
|
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.
|
Mayo Clin Proc
|
2006
|
1.03
|
|
28
|
A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology.
|
Pain Med
|
2010
|
1.02
|
|
29
|
Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies.
|
Pain Med
|
2008
|
1.01
|
|
30
|
Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition.
|
Anesthesiology
|
2007
|
0.98
|
|
31
|
Cutaneous tactile allodynia associated with microvascular dysfunction in muscle.
|
Mol Pain
|
2008
|
0.93
|
|
32
|
Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
|
Pain
|
2013
|
0.89
|
|
33
|
Imaging studies in Freund's complete adjuvant model of regional polyarthritis, a model suitable for the study of pain mechanisms, in the rat.
|
Arthritis Rheum
|
2011
|
0.88
|
|
34
|
CNS mastitis: nothing to worry about?
|
Vet Microbiol
|
2008
|
0.85
|
|
35
|
Characterization of a model of cutaneous inflammatory pain produced by an ultraviolet irradiation-evoked sterile injury in the rat.
|
J Neurosci Methods
|
2005
|
0.84
|
|
36
|
Neuropathic pain: a crisis of definition?
|
Anesth Analg
|
2003
|
0.83
|
|
37
|
A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain.
|
J Pain
|
2002
|
0.83
|
|
38
|
Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy.
|
J Pharmacol Sci
|
2008
|
0.82
|
|
39
|
Unpleasant odors increase pain processing in a patient with neuropathic pain: psychophysical and fMRI investigation.
|
Pain
|
2005
|
0.80
|
|
40
|
Novel therapies for the control and prevention of neuropathic pain.
|
Neurotherapeutics
|
2009
|
0.78
|
|
41
|
Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.
|
J Pain
|
2013
|
0.77
|
|
42
|
Peripheral neuropathy in a woman with breast cancer.
|
J Pain
|
2006
|
0.77
|
|
43
|
Objectifying CRPS-I.
|
Pain
|
2008
|
0.76
|
|
44
|
Response to "A new definition of neuropathic pain".
|
Pain
|
2012
|
0.75
|
|
45
|
Questions concerning the incidence and prevalence of complex regional pain syndrome type I (RSD).
|
Pain
|
2003
|
0.75
|
|
46
|
Effects of topical combinations of clonidine and pentoxifylline on capsaicin-induced allodynia and postcapsaicin tourniquet-induced pain in healthy volunteers: a double-blind, randomized, controlled study.
|
Pain
|
2016
|
0.75
|
|
47
|
Dissociation between cutaneous and deep sensibility in central post-stroke pain (CPSP).
|
Pain
|
2002
|
0.75
|